Middle East Pharmaceutical Industries Company
SAU: 4016.SR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Saudi Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Mohammed Maher MohammedLotfi Al-Ghannam
- Employees
- 731
- Headquarters
- Riyadh, Saudi Arabia
- IPO year
- 2024
- Market cap
- SAR 2.2B
- Website
- https://www.avalonpharmaceutical.com
Loading 4016…
Loading profile data…Frequently asked questions about 4016
What does Middle East Pharmaceutical Industries Company (4016.SR) do?
Middle East Pharmaceutical Industries Company (MEPIC), established in Riyadh, Saudi Arabia, in 1998, is a global pharmaceutical entity. The company's core activities encompass the entire lifecycle of generic medicines and various pharmaceutical products, from research and development to manufacturing and sales, catering to both local and interna...
Where does 4016.SR trade?
Middle East Pharmaceutical Industries Company (4016.SR) trades on the Saudi Exchange.
What sector is 4016.SR in?
Middle East Pharmaceutical Industries Company (4016.SR) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Middle East Pharmaceutical Industries Company?
Mohammed Maher MohammedLotfi Al-Ghannam is the chief executive officer of Middle East Pharmaceutical Industries Company (4016.SR).
Where is Middle East Pharmaceutical Industries Company headquartered?
Middle East Pharmaceutical Industries Company is headquartered in Saudi Arabia.
When did 4016.SR go public?
Middle East Pharmaceutical Industries Company (4016.SR) completed its initial public offering in 2024.